LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 20 filers reported holding LAVA THERAPEUTICS NV in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $374,742 | -52.9% | 225,748 | -0.8% | 0.00% | -66.7% |
| Q4 2022 | $796,184 | -61.9% | 227,481 | -50.3% | 0.00% | -25.0% |
| Q3 2022 | $2,090,026 | +55.7% | 457,342 | +0.5% | 0.00% | +100.0% |
| Q2 2022 | $1,342,045 | -34.2% | 454,946 | -1.9% | 0.00% | -33.3% |
| Q1 2022 | $2,040,298 | +60.0% | 463,772 | +100.0% | 0.00% | 0.0% |
| Q4 2021 | $1,275,000 | -6.0% | 231,884 | +1.2% | 0.00% | -25.0% |
| Q3 2021 | $1,356,000 | -71.8% | 229,121 | -48.1% | 0.00% | -42.9% |
| Q2 2021 | $4,802,000 | +43.5% | 441,326 | +100.3% | 0.01% | -30.0% |
| Q1 2021 | $3,347,000 | – | 220,363 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,070,558 | $5,097,126 | 0.34% |
| Bruce & Co., Inc. | 671,874 | $1,115,311 | 0.30% |
| Redmile Group, LLC | 2,074,372 | $3,443,458 | 0.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 140,291 | $232,883 | 0.10% |
| Alpha Wave Global, LP | 119,516 | $198,397 | 0.07% |
| Artal Group S.A. | 200,000 | $332 | 0.02% |
| Cannell Capital | 17,955 | $29,805 | 0.01% |
| CANTOR FITZGERALD, L. P. | 53,299 | $88,476 | 0.00% |
| UBS OCONNOR LLC | 20,502 | $34,033 | 0.00% |
| AXA S.A. | 225,748 | $374,742 | 0.00% |